131 related articles for article (PubMed ID: 8499751)
1. [Serum IgG concentrations and antibody titer of burn patients after preventive intravenous IgG substitution with a Pseudomonas immunoglobulin].
Stuttmann R; Hartert M; Jahn M; Spilker G; Doehn M
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():48-55. PubMed ID: 8499751
[TBL] [Abstract][Full Text] [Related]
2. [Prevention with pseudomonas immune globulin in burn injury patients with inhalation trauma: does it have an effect on lung function and outcome?].
Stuttmann R; Hebebrand D; Hartert M; Spilker G; Doehn M
Klin Wochenschr; 1991; 69 Suppl 26():168-77. PubMed ID: 1813715
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
Infection; 1987; 15 Suppl 2():S51-9. PubMed ID: 3112021
[TBL] [Abstract][Full Text] [Related]
4. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
[TBL] [Abstract][Full Text] [Related]
5. [Pseudomonas immunoglobulin prophylaxis in patients with burn injuries].
Stuttmann R; Petrovici V; Hartert M
Infection; 1987; 15 Suppl 2():S71-5. PubMed ID: 3112025
[TBL] [Abstract][Full Text] [Related]
6. The response of immunoglobulins to infection after thermal and nonthermal injury.
Hershman MJ; Cheadle WG; George CD; Cost KM; Appel SH; Davidson PF; Pork HC
Am Surg; 1988 Jul; 54(7):408-11. PubMed ID: 3389587
[TBL] [Abstract][Full Text] [Related]
7. [Supplemental infection therapy with i.v. immunoglobulins (polyvalent IgG and Pseudomonas IgG)--results of an observational case study with 163 patients].
Pilz G; Kääb S; Bujdoso O; Neumann R; Werdan K
Klin Wochenschr; 1991; 69 Suppl 26():178-84. PubMed ID: 1813716
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
Infection; 1987; 15(1):60-8. PubMed ID: 3570485
[TBL] [Abstract][Full Text] [Related]
9. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
Zellner PR; Zwissler O; Metzger E
Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
[TBL] [Abstract][Full Text] [Related]
10. [Hyperbaric oxygenation in burns].
Kaiser W; Berger A; von der Lieth H; Heymann H
Handchir Mikrochir Plast Chir; 1985 Nov; 17(6):326-30. PubMed ID: 4076851
[TBL] [Abstract][Full Text] [Related]
11. Effect of lymphocytotherapy on the course of experimental Pseudomonas sepsis.
Munster AM; Leary AG; Spicer SS; Fisher MW
Ann Surg; 1974 Apr; 179(4):482-8. PubMed ID: 4593102
[No Abstract] [Full Text] [Related]
12. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
[No Abstract] [Full Text] [Related]
13. Infection in the burned upper extremity.
Levine NS; Salisbury RE
Major Probl Clin Surg; 1976; 19():47-62. PubMed ID: 176539
[TBL] [Abstract][Full Text] [Related]
14. [Prevention using a Pseudomonas immunoglobulin in burn patients].
Stuttmann R; Petrovici V; Hartert M
Infection; 1987; 15(1):80-4. PubMed ID: 3106234
[TBL] [Abstract][Full Text] [Related]
15. [Use of pseudomonas immunoglobulin. Indications and results].
Werdan K; Melnitzki S; Pilz G; Reuschel-Janetschek E
Anasth Intensivther Notfallmed; 1989 Jun; 24(3):153-61. PubMed ID: 2504071
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of plasma humoral recognition factor activity following burn injury.
Goldman AS; Rudloff HB; McNamee R; Loose LD; DiLuzio NR
J Reticuloendothel Soc; 1974 Mar; 15(3):193-8. PubMed ID: 4838130
[No Abstract] [Full Text] [Related]
17. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients.
Gonzáles Ayala SE; Daroda M; Villa J; Cecchini E; Vich J
Panminerva Med; 1983; 25(3):203-8. PubMed ID: 6422426
[No Abstract] [Full Text] [Related]
18. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
Hunt JL; Purdue GF
J Trauma; 1988 Feb; 28(2):146-51. PubMed ID: 3126302
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
Minukhin VV; Tsyganenko AIa
Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
[TBL] [Abstract][Full Text] [Related]
20. Immunoserology of Pseudomonas aeruginosa infections in man. III. Site of infection, duration of the presence of Pseudomonas aeruginosa and antibody response.
Petrás G; Adám M; Lányi B; Konkoly Thege M; Szentmihályi A
Acta Microbiol Hung; 1984; 31(2):109-16. PubMed ID: 6464657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
